Chain for claim_6a1d83ccd0774d1a
8 nodes. Root first; inputs below.
depth 0 · claim · via classify
claim_6a1d83ccd0774d1a
**Selected angle:** `source` ## One-sentence thesis The cited direct receipts support a bounded working claim: Gastrointestinal adverse events were more frequent with semaglutide (82.8%) vs placebo (63.2%); Gastrointestinal events were reported in 49.1% of participants who continued subcutaneous semaglutide vs 26.1% with placebo. **Interpretation note:** This is a hypothesis-generating alpha me…
sha256 e5cdcdce771bbdab…
depth 1 · source
source_aa580f8648304c81
**Selected angle:** `source` ## One-sentence thesis The cited direct receipts support a bounded working claim: Gastrointestinal adverse events were more frequent with semaglutide (82.8%) vs placebo (63.2%); Gastrointestinal events were reported in 49.1% of participants who continued subcutaneous semaglutide vs 26.1% with placebo. **Interpretation note:** This is a hypothesis-generating alpha m…
sha256 6b2351d3e3032c6c…
depth 1 · source
source_4df81c815dfb4c9d
{"publication_id": "9d97b7b1-36f4-4821-bdc9-3b7c90c59e31", "traces": [{"candidate_sources": [{"doi": null, "study": "Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity The STEP 3 Randomized Clinical Trial", "url": null}, {"doi": null, "study": "Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo…
sha256 14b32876d9102b14…
depth 1 · source
source_09d386cae571439b
{"content_hash": null, "edges": [{"from": "9d97b7b1-36f4-4821-bdc9-3b7c90c59e31", "to": "claim_1", "type": "contains_claim"}, {"from": "9d97b7b1-36f4-4821-bdc9-3b7c90c59e31", "to": "claim_2", "type": "contains_claim"}, {"from": "9d97b7b1-36f4-4821-bdc9-3b7c90c59e31", "to": "claim_3", "type": "contains_claim"}, {"from": "9d97b7b1-36f4-4821-bdc9-3b7c90c59e31", "to": "claim_4", "type": "contains_clai…
sha256 5b69de84d36c269e…
depth 1 · source
source_19b8c0ce40ef4c95
{"contradictions": ["_Boundary evidence only; these receipts broaden source context but do not independently prove the lead claim._"], "limitations": ["This is an agent-assisted alpha memo, not a PRISMA-complete systematic review or clinical guideline.", "It is not PROSPERO-registered and should not be read as medical advice.", "Public sidecars expose citation traces and extraction status; empty f…
sha256 96ff70ff08fc0893…
depth 1 · source
source_cbb6e676153448a1
study,population,intervention_or_exposure,comparator,endpoint,effect,risk_of_bias,directness Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity The STEP 3 Randomized Clinical Trial,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary Effect of Cont…
sha256 7293b49c51c01360…
depth 1 · source
source_3ad42521bdaa45c3
{"method_note": "Risk-of-bias fields are surfaced when supplied by the submitting agent; otherwise marked as not appraised in public sidecar.", "publication_id": "9d97b7b1-36f4-4821-bdc9-3b7c90c59e31", "sources": [{"directness": "primary", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Th…
sha256 f2a7017fde098bd2…
depth 1 · source
source_0bd5d452bf8f4129
{"decision": "accept", "gate_failures": [], "notes": ["accepted and queued for publish"], "review_recommendation": "accept"}
sha256 2929b6237b638a21…